[1] ROA JC,GARCIA P,KAPOOR VK,et al.Gallbladder cancer[J].Nat Rev Dis Primers,2022,8(1):69.
[2] 蒋崔楠,杨琴,李明,等.胆囊癌新辅助化疗研究进展[J].现代肿瘤医学,2021,29(19):3507-3510. JIANG CN,YANG Q, LI M,et al.Progress in neoadjuvant chemotherapy for gallbladder cancer[J].Modern Oncology,2021,29(19):3507-3510.
[3] XU S,JIANG C,LIN R,et al.Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy[J].J Exp Clin Cancer Res,2021,40(1):373.
[4] HU Z,CHEN G,ZHAO Y,et al.Exosome-derived circCCAR1 promotes CD8+ T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma[J].Mol Cancer,2023,22(1):55.
[5] CHEN Z,XU Z,WANG Q,et al.Exosome-delivered circRNA circSYT15 contributes to cisplatin resistance in cervical cancer cells through the miR-503-5p/RSF1 axis[J].Cell Cycle,2023,22(20):2211-2228.
[6] WEI SL,YE JJ,SUN L,et al.Exosome-derived circKIF20B suppresses gefitinib resistance and cell proliferation in non-small cell lung cancer[J].Cancer Cell Int,2023,23(1):129.
[7] YAO J,ZHANG HY,GU S,et al.Circular RNA-AnnexinA7 accelerates cisplatin resistance in non-small cell lung cancer via modulating microRNA-545-3p to mediate Cyclin D1[J].Acta Biochim Pol,2023,70(2):295-304.
[8] YIN Y,LI J,RONG J,et al.Circ_0067934 reduces JNK phosphorylation through a microRNA-545-3p/PPA1 axis to enhance tumorigenesis and cisplatin resistance in ovarian cancer[J].Immunopharmacol Immunotoxicol,2022,44(2):261-274.
[9] HU C,XIA R,ZHANG X,et al.circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis[J].Mol Cancer,2022,21(1):24.
[10] CHEN ZW,HU JF,WANG ZW,et al.Circular RNA circ-MTHFD1L induces HR repair to promote gemcitabine resistance via the miR-615-3p/RPN6 axis in pancreatic ductal adenocarcinoma[J].J Exp Clin Cancer Res,2022,41(1):153.
[11] HONG C,LISHAN W,PENG X,et al.Hsa_circ_0074298 promotes pancreatic cancer progression and resistance to gemcitabine by sponging miR-519 to target SMOC[J].J Cancer,2022,13(1):34-50.
[12] HUI B,ZHOU C,XU Y,et al.Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085[J].J Nanobiotechnology,2024,22(1):62.
[13] XIA W,CHEN W,NI C,et al.Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway[J].Breast Cancer Res,2023,25(1):85.
[14] LI G,LAN Q.Exosome-mediated transfer of circ-GLIS3 enhances temozolomide resistance in glioma cells through the miR-548m/MED31 axis[J].Cancer Biother Radiopharm,2023,38(1):62-73.
[15] ZHANG L,YU R,LI C,et al.Circ_0026416 downregulation blocks the development of colorectal cancer through depleting MYO6 expression by enriching miR-545-3p[J].World J Surg Oncol,2021,19(1):299.
[16] SONG Y,WANG J,XU J,et al.Circ_0018909 knockdown inhibits the development of pancreatic cancer via the miR-545-3p/FASN axis and reduces macrophage polarization to M2[J].J Biochem Mol Toxicol,2023,37(4):e23293.
[17] ZHANG Y,YU Y,CAO X,et al.Role of lncRNA FAM83H antisense RNA1(FAM83H-AS1) in the progression of non-small cell lung cancer by regulating the miR-545-3p/heparan sulfate 6-O-sulfotransferase(HS6ST2) axis[J].Bioengineered,2022,13(3):6476-6489.
[18] LIMB C,LIU DSK,VENO MT,et al.The role of circular RNAs in pancreatic ductal adenocarcinoma and biliary-tract cancers[J].Cancers(Basel),2020,12(11):3250.
[19] GAO Y,LIU C,XU X,et al.Circular RNA sterile alpha motif domain containing 4A contributes to cell 5-fluorouracil resistance in colorectal cancer by regulating the miR-545-3p/6-phosphofructo-2-kinase/fructose-2,6-bisphosphataseisotype 3 axis[J].Anticancer Drugs,2022,33(6):553-563.
[20] DU D,CAO X,DUAN X,et al.Blocking circ_0014130 suppressed drug resistance and malignant behaviors of docetaxel resistance-acquired NSCLC cells via regulating miR-545-3p-YAP1 axis[J].Cytotechnology,2021,73(4):571-584.
[21] ZHU L,ZHU X,WU Y.Effects of glucose metabolism,lipid metabolism,and glutamine metabolism on tumor microenvironment and clinical implications[J].Biomolecules,2022,12(4):580.
[22] YANG WH,QIU Y,STAMATATOS O,et al.Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy[J].Trends Cancer,2021,7(8):790-804.
[23] ZHOU X,LIU K,CUI J,et al.Circ-MBOAT2 knockdown represses tumor progression and glutamine catabolism by miR-433-3p/GOT1 axis in pancreatic cancer[J].J Exp Clin Cancer Res,2021,40(1):124.
[24] WU B,CHEN Y,XIE X,et al.Circ_0001273 downregulation inhibits the growth,migration and glutamine metabolism of esophageal cancer cells via targeting the miR-622/SLC1A5 signaling axis[J].Thorac Cancer,2022,13(12):1795-1805.
[25] CAI Y,DONG Z,WANG J.circ_0000808 promotes the development of non-small cell lung cancer by regulating glutamine metabolism via the miR-1827/SLC1A5 axis[J].World J Surg Oncol,2022,20(1):329.